The pulmonary delivery of insulin may reduce the need for multiple daily subcutaneous injections of insulin for many patients with diabetes. The lungs are an attractive site for delivery of insulin ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

WASHINGTON (AP) - The first inhalable version of insulin won federal approval Friday, giving millions of adult diabetics an alternative to some of the injections they now endure. The Food and Drug ...

Dec. 31, 2003 — Preprandial inhaled insulin via AERx insulin diabetes management system (iDMS) is as effective as preprandial subcutaneous insulin in patients with type 2 diabetes. Results of the ...

A Prescription Drug User Fee Act target date of May 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...

This is an exciting time in the treatment of diabetes. Continuous, subcutaneous insulin infusion and continuous glucose monitoring technologies are making optimal glucose control accessible to more ...

ORLANDO -- For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control -- for those who used it as intended, the ...

SACRAMENTO, Calif. — There’s a form of insulin that’s changing the lives of diabetics who use it, but doctors and patients alike say it doesn’t have widespread name recognition. It’s called Afrezza.

French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among adults with type 2 diabetes, ...